Vincent G DeMarco

5PUBLICATIONS
0CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Nutrigenomics and personalised nutritionMolecular medicineCancer geneticsMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 22, 2021
Sacubitril/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffness.

Annayya R Aroor, Srinivas Mummidi, Juan Carlos Lopez-Alvarenga

|Mar 27, 2019
The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat.

Javad Habibi, Annayya R Aroor, Nitin A Das

|Aug 01, 2018
Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury.

Annayya R Aroor, Nitin A Das, Andrea J Carpenter

|Apr 20, 2018
The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin.

Annayya R Aroor, Camila Manrique-Acevedo, Vincent G DeMarco

|Jan 15, 2017
Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes.

Javad Habibi, Annayya R Aroor, James R Sowers

Pageof 1

Frequent Collaborators